<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="474">
  <stage>Registered</stage>
  <submitdate>9/09/2005</submitdate>
  <approvaldate>13/09/2005</approvaldate>
  <actrnumber>ACTRN12605000383662</actrnumber>
  <trial_identification>
    <studytitle>Use of ethanol to prevent infection in tunnelled intravenous catheters in haematology patients treated with chemotherapy.</studytitle>
    <scientifictitle>A Prospective double-blind randomised clinical trial of 70% ethanol to prevent luminal microbial colonisation of tunneled catheters and associated catheter related sepsis, in haematology patients treated with chemotherapy.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Intravascular tunneled central line catheter related sepsis.</healthcondition>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Other blood disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>To assess the efficacy ans safety of 70% ethanol in preventing luminal colonisation of central venous tunnelled catheters. 70% Ethanol or Heparin/saline will be installed into the lumen of the catheter daily for a duration of 2 hours before being removed. This intervention will continue for the length of the hospital admission for the patient or to a limit of 30 days.</interventions>
    <comparator>Control (heparin/saline)</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Will the introduction of 70% Alcohol down the lumen of a central line catheter reduce the incidence of bacterial colonisation of the lumen in haematology in-patients receiving chemotherapy.</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To assess the usefulness of the FAS brush in diagnosis of Catheter related sepsis.</outcome>
      <timepoint>Fas brushing will occur at the following time points in the trial.
1. First febrile episode
2. Second febrile episode or if temperature continues for 7 days
3. Discharge from Hospital.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Consent. Central venous catheter in-situ For chemotherapy requiring an in-patient stay for &gt;5 days. Haematological malignancy / Bone marrow transplant.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Known allergy to ethanol. Out-patient chemotherapy. Positive central line cultures within 7 days of entry into study. Elevated LFTs (&gt;2.5 times above ULN). Known history of alcoholism. Pregnancy/lactating women Febrile above 38.0deg at entry.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>There was one unblinded pharmacist who kept the randomisations in a different department to where the study was being conducted. Randomisation occurred by fax.</concealment>
    <sequence>Sequence generation was performed using Microsoft Excel 97.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>3/01/2002</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Canterbury District Health Board</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Canterbury District Health Board Research Fund</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Upper South regional Ethics committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Joanne Sanders</name>
      <address>Canterbury Health Laboratories
PO Box 151
Christchurch</address>
      <phone>+64 3 3640377</phone>
      <fax>+64 3 3640750</fax>
      <email>joanne.sanders@cdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Alan Pithie</name>
      <address>Christchurch Hospital 
PO Box 4710
Christchurch</address>
      <phone>+64 3 3640640</phone>
      <fax />
      <email>alan.pithie@cdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>